[Form 4] The Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

The filing reports insider sales by Corey Baker, Chief Financial Officer of Vita Coco Company, Inc. (COCO). Mr. Baker sold 1,000 shares on 09/09/2025 at $38.40 and 1,000 shares on 09/10/2025 at $38.16 under a Rule 10b5-1 trading plan, reducing his direct common stock holdings from 41,754 to 39,754 shares. The Form 4 also discloses outstanding non-qualified stock options exercisable into a total of 61,197 shares across five option grants with exercise prices ranging from $16.91 to $33.36 and various vesting schedules.

Positive

• Sales were conducted under a Rule 10b5-1 trading plan, indicating pre-planned, compliant dispositions
• Reporting person retains significant equity and option positions: 39,754 shares directly and 61,197 shares underlying options

Negative

• CFO sold 2,000 shares over two days, which reduces direct ownership from 41,754 to 39,754 shares
• Some option exercise prices (e.g., $33.36) are close to reported sale prices, potentially limiting near-term upside for those grants

Insights

Financial Analyst

TL;DR CFO executed planned sales under a 10b5-1 program and retains substantial equity plus vested and unvested options.

The 2,000-share sales were effected pursuant to a Rule 10b5-1 plan, indicating prearranged dispositions rather than opportunistic trades. Proceeds per share were $38.40 and $38.16. Following the transactions Mr. Baker still directly holds 39,754 shares and controls 61,197 underlying shares from options, many of which are vested or partially vested. From a financial perspective these transactions modestly reduce insider equity but leave significant potential upside via options with exercise prices below recent sale prices.

Corporate Governance Expert

TL;DR Transactions comply with Rule 10b5-1 disclosure; continued holdings and option grants align with standard executive compensation practices.

The Form 4 states the sales were made pursuant to a Rule 10b5-1 trading plan and the filing is signed by an attorney-in-fact, consistent with standard governance processes. The disclosure lists detailed vesting schedules and exercise prices for multiple option grants, which provides transparency on incentive timing. There is no indication in this filing of unusual governance concerns or impropriety based solely on these reported transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BAKER COREY

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2025		S(1)		1,000	D	$38.4	40,754	D
Common Stock	09/10/2025		S(1)		1,000	D	$38.16	39,754	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$16.91							(2)	03/10/2033	Common Stock	14,205		14,205	D
Non-Qualified Stock Option (right to buy)	$24.35							(3)	05/10/2033	Common Stock	13,481		13,481	D
Non-Qualified Stock Option (right to buy)	$26.18							(4)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (right to buy)	$27.59							(3)	08/07/2033	Common Stock	11,547		11,547	D
Non-Qualified Stock Option (right to buy)	$33.36							(5)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The stock option vests in four equal annual installments beginning on March 10, 2024.

3. The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.

4. The stock option vests in four equal annual installments beginning on March 4, 2025.

5. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	By: Alison Klein, Attorney-in-Fact For: Corey Baker	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did COCO CFO Corey Baker sell and when?

Corey Baker sold 1,000 shares on 09/09/2025 at $38.40 and 1,000 shares on 09/10/2025 at $38.16.

Were the insider sales by COCO reported under a trading plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan.

How many COCO shares does Corey Baker own after the reported sales?

After the reported sales Mr. Baker directly owns 39,754 shares of common stock.

What derivative securities does the filing disclose for COCO insider?

The Form 4 discloses non-qualified stock options exercisable into a total of 61,197 shares with exercise prices from $16.91 to $33.36 and varying vesting schedules.

Who signed the Form 4 for Corey Baker?

The Form 4 was signed By: Alison Klein, Attorney-in-Fact for Corey Baker on 09/11/2025.